The emergence of bacterial strains resistant to topical antimicrobials in both human and veterinary medicine has raised concerns over retaining the efficacy of these preparations. Yet, little information is available regarding the use of topical antimicrobials in either sector for planning targeted interventions. This study aims to quantify the use of topical antimicrobials in 44 Dutch companion animal clinics before and during their participation in an antimicrobial stewardship programme (ASP), to explore the effect of the intervention on topical antimicrobial use (AMU). Hence, prescription and clinic animal population data, collected from July 2012 until June 2018 were used. Specifically, the period from July 2012 until June 2015 was defined as pre-intervention period, whereas clinics started to participate in the ASP from March 2016 onwards. As quantification metric, the Defined Daily Dose for Animals (DDDA) was used and a mixed effect times series model with auto-regression was applied to monthly topical AMU data. The intervention effect was modelled using a step function with a change in (linear) time trend and clinic characteristics, as potential determinants of topical AMU, were assessed using a multivariable regression model. A seasonal pattern was identified, in the pre-intervention period, where topical AMU was highest in July-August and lowest in February-March. In addition, total topical AMU appeared to significantly decrease over time in the pre-intervention period and the proportion of dogs in the clinic was positively associated with topical AMU. The intervention effect was significant only for second line and for skin product AMU. This study demonstrates that during participation in an ASP, second line and skin product AMU decreased in Dutch companion animal clinics. Additionally, this study demonstrates the existence of a seasonal effect and a decrease in topical AMU over time already before introduction of a targeted intervention.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101466PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0283956PLOS

Publication Analysis

Top Keywords

topical amu
24
dutch companion
12
companion animal
12
animal clinics
12
topical antimicrobials
12
pre-intervention period
12
topical
10
amu
9
topical antimicrobial
8
participation antimicrobial
8

Similar Publications

Article Synopsis
  • - FMX101 4% is a topical foam formulation of minocycline approved for treating moderate-to-severe acne vulgaris, and a study was conducted to evaluate its effectiveness and safety among Chinese patients.
  • - In a phase 3 trial involving 372 subjects, results showed that FMX101 4% led to a significant reduction in inflammation lesion count (ILC) and noninflammatory lesion count (nILC), along with a higher treatment success rate compared to a control foam after 12 weeks.
  • - The treatment was generally safe and well-tolerated, with mostly mild-to-moderate side effects and no serious adverse events linked to the treatment.
View Article and Find Full Text PDF

Role of Topical Estrogen in Outcomes of Myringoplasty: Does it Really Affect the Results of Graft Success and Hearing Thresholds?

Indian J Otolaryngol Head Neck Surg

June 2024

Department of Otorhinolaryngology-Head and Neck Surgery, J.N. Medical College, A.M.U., Aligarh, U.P. India.

The tympanic membrane forms a barrier between the external auditory canal and the middle ear. In the inactive mucosal type of chronic otitis media, there is a perforation in the tympanic membrane which is surgically managed by Myringoplasty. Estrogen as a growth factor has been shown to have a mitogenic effect on keratinocytes thus hastening the rate of epithelialization following injury.

View Article and Find Full Text PDF

The emergence of bacterial strains resistant to topical antimicrobials in both human and veterinary medicine has raised concerns over retaining the efficacy of these preparations. Yet, little information is available regarding the use of topical antimicrobials in either sector for planning targeted interventions. This study aims to quantify the use of topical antimicrobials in 44 Dutch companion animal clinics before and during their participation in an antimicrobial stewardship programme (ASP), to explore the effect of the intervention on topical antimicrobial use (AMU).

View Article and Find Full Text PDF
Article Synopsis
  • The European Society of Gynaecological Oncology and other organizations created consensus statements to enhance care for patients with vaginal intraepithelial neoplasia (VaIN).
  • Treatment for VaIN depends on the lesion's grade, with follow-ups for low-grade VaIN (VaIN 1) and treatment required for high-grade (VaIN 2-3), highlighting that management should be personalized.
  • Surgical excision is the primary treatment; alternatives like CO laser and topical agents exist, with imiquimod showing the best outcomes, while brachytherapy is suited for specific cases, and consistent follow-up is essential due to the recurring nature of VaIN.
View Article and Find Full Text PDF
Article Synopsis
  • The consensus statements developed by ESGO, ISSVD, ECSVD, and EFC aim to enhance care for patients with vaginal intraepithelial neoplasia (VaIN), outlining management strategies based on lesion grade.
  • For low-grade VaIN (VaIN 1), follow-up is usually sufficient, while high-grade VaIN (VaIN 2-3) requires treatment, with surgical excision being the primary method if invasion is suspected.
  • Treatments like CO2 laser and topical agents, especially Imiquimod, are effective, but surgical options are often necessary for cases post-hysterectomy, and patients should be closely monitored due to the risk of recurrence.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!